Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
US |
|
Kronos Worldwide Inc
NYSE:KRO
|
US |
|
Askoll Eva SpA
MIL:EVA
|
IT |
|
Alcon AG
SIX:ALC
|
CH |
|
Champion Pacific Indonesia Tbk PT
IDX:IGAR
|
ID |
|
Sensus Healthcare Inc
NASDAQ:SRTS
|
US |
|
Freehold Royalties Ltd
TSX:FRU
|
CA |
|
Ariana Resources PLC
F:4A6
|
UK |
Wall St Price Targets
REGN Price Targets Summary
Regeneron Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for REGN is 847.04 USD with a low forecast of 647.41 USD and a high forecast of 1 050 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is REGN's stock price target?
Price Target
847.04
USD
According to Wall Street analysts, the average 1-year price target for REGN is 847.04 USD with a low forecast of 647.41 USD and a high forecast of 1 050 USD.
What is the Revenue forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
11%
The compound annual growth rate for Operating Income over the next 8 years is 11%.
What is the Net Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
8%
The compound annual growth rate for Net Income over the next 8 years is 8%.
